Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

One-Page MedGuide For Long-acting Opioids Sets Stage For Retooling MedGuide Format

Jul 16 2012

• By Cathy Dombrowski

Related Content

Single Patient Drug Leaflet Logical, Complicated To Achieve - Woodcock

Oct 05 2009

Opioid Training Syllabus Increases Emphasis On Patient Monitoring In Final REMS Blueprint

Jul 16 2012

Mandatory Training For Opioid Prescribers Remains Stuck On Drawing Board

Jul 16 2012

OxyContin Abuse-Deterrent Formulation Has Addicts Switching To Heroin

Jul 16 2012

Opioid Prescriber Knowledge Assessment Due Year After Patient Assessment

Jul 16 2012

Long-Acting Opioid REMS Tally: FDA Lists 12 Brand, 23 Generic

Jul 16 2012

FDA's Chicken Or Egg Question For Pharmacy Leaflets: Should Benefit Or Risk Come First?

Jan 24 2011

REMS And Benefits? FDA, Industry Debate Moving Beyond Safety Information

Aug 02 2010

Related Companies

Johnson & Johnson

Purdue Pharma L.P.

Additional Topics

United States Risk Management BioPharmaceutical

More from United States

More from North America

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window